CGM
New CEO of Dexcom, Jake Leach, joined MobiHealthNews at the JPM Healthcare Conference to discuss his leadership priorities, CGM access and the role of wearables in preventive care.
The company says the new facility will create hundreds of jobs and expand production capabilities for continuous glucose monitoring systems.
The announcement comes less than a year after Dexcom announced a strategic partnership and $75 million investment in the health-tracking ring maker.
The company's patch uses intradermal electrochemical sensors to monitor glucose levels and provide metabolic insights to individuals with type 2 diabetes not on insulin.
The CGM biosensor offers high antinoise ability and tunable sensitivity and resolution.
The hydrogel-based sensor can continuously monitor cholesterol and lactate on the skin.
Also, new AI-powered mobile apps in Hong Kong support at-home stroke rehabilitation and the mental health of parents of children with special education needs.
i-SENS is also seeking CE certification for its CGM product in Europe.
The CGM-based service will begin in Q4.
Also, medical device unicorn Molbio has taken a 70% stake in digital x-ray manufacturer Prognosys.